Chen Wan-Shan
SEC CIK 2001438 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BLTE | BELITE BIO, INC | Dir | 9,096 | — | $198.5K | 1 | 2026-04-09 | 2026-04-09 |
Most active insiders at BLTE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Yu-Hsin | CEO, Dir | — | $20.82M |
| 2 | Chuang Hao-Yuan | CFO, Dir | — | $14.00M |
| 3 | Scholl Hendrik Peter | Chief Medical Off | — | $2.86M |
| 4 | MATA NATHAN L. | CSO | — | $2.67M |
| 5 | Chen Wan-Shan | Dir | — | $198.5K |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-13 16:15 | 2026-04-09 | BLTE | BELITE BIO, INC | Chen Wan-Shan | Dir | S - Sale | $180.43 | -1,100 | 9,096 | -11% | -$198.5K |
Purchase Sale Sale after option exercise All abbreviations